145 related articles for article (PubMed ID: 3690188)
21. [A case of advanced testicular seminoma--chemotherapy and serum marker].
Nakamura K; Hagiwara M; Aikawa A; Deguchi N; Tazaki H; Takeshita E; Ito S
Gan No Rinsho; 1983 Dec; 29(15):1779-82. PubMed ID: 6199531
[TBL] [Abstract][Full Text] [Related]
22. Human chorionic gonadotropin-positive seminoma patients: A registry compiled by the global germ cell tumor collaborative group (G3).
Seidel C; Daugaard G; Nestler T; Tryakin A; Fedyanin M; Fankhauser C; Hermanns T; Aparicio J; Heinzelbecker J; Paffenholz P; Heidenreich A; De Giorgi U; Cathomas R; Lorch A; Fingerhut A; Gayer F; Bremmer F; Giannatempo P; Necchi A; Aurilio G; Casadei C; Tran B; Dieckmann KP; Brito M; Ruf C; Oing C; Bokemeyer C
Eur J Cancer; 2020 Jun; 132():127-135. PubMed ID: 32361383
[TBL] [Abstract][Full Text] [Related]
23. The seminoma decoy: measurement of serum human chorionic gonadotropin in patients with seminoma.
Cochran JS
J Urol; 1976 Oct; 116(4):465-6. PubMed ID: 1053336
[TBL] [Abstract][Full Text] [Related]
24. Should an elevated human chorionic gonadotropin titer alter therapy for seminoma?
Swartz DA; Johnson DE; Hussey DH
J Urol; 1984 Jan; 131(1):63-5. PubMed ID: 6690749
[TBL] [Abstract][Full Text] [Related]
25. [Giant seminoma of the left testis: a case report].
Saiko Y; Suzuki A; Saito I; Soejima K
Hinyokika Kiyo; 1992 Jan; 38(1):85-7. PubMed ID: 1546576
[TBL] [Abstract][Full Text] [Related]
26. Hyperglycosylated human chorionic gonadotropin in serum of testicular cancer patients.
Lempiäinen A; Hotakainen K; Blomqvist C; Alfthan H; Stenman UH
Clin Chem; 2012 Jul; 58(7):1123-9. PubMed ID: 22529110
[TBL] [Abstract][Full Text] [Related]
27. Neuron-specific enolase--a serum tumour marker in seminoma?
Fosså SD; Klepp O; Paus E
Br J Cancer; 1992 Feb; 65(2):297-9. PubMed ID: 1739633
[TBL] [Abstract][Full Text] [Related]
28. The management of patients with clinical stage I nonseminomatous testicular tumors and persistently elevated serologic markers.
Saxman SB; Nichols CR; Foster RS; Messemer JE; Donohue JP; Einhorn LH
J Urol; 1996 Feb; 155(2):587-9. PubMed ID: 8558665
[TBL] [Abstract][Full Text] [Related]
29. False positive beta-human chorionic gonadotropin in testicular cancer.
Mohler JL; Siami PF; Flanigan RC
Urology; 1987 Sep; 30(3):252-4. PubMed ID: 2442873
[TBL] [Abstract][Full Text] [Related]
30. Experience with beta-HCG-positive seminoma.
Kuber W; Kratzik C; Schwarz HP; Susani M; Spona J
Br J Urol; 1983 Oct; 55(5):555-9. PubMed ID: 6194845
[TBL] [Abstract][Full Text] [Related]
31. Serum alpha-fetoprotein and human chorionic gonadotropin in patients with seminoma.
Lange PH; Nochomovitz LE; Rosai J; Fraley EE; Kennedy BJ; Bosl G; Brisbane J; Catalona WJ; Cochran JS; Comisarow RH; Cummings KB; deKernion JB; Einhorn LH; Hakala TR; Jewett M; Moore MR; Scardino PT; Streitz JM
J Urol; 1980 Oct; 124(4):472-8. PubMed ID: 6158584
[TBL] [Abstract][Full Text] [Related]
32. Serum lactate dehydrogenase isoenzyme 1 in patients with seminoma stage I followed with surveillance.
von Eyben FE; Madsen EL; Blaabjerg O; Petersen PH; Jacobsen GK; Specht L; Pedersen BN; von der Maase H
Acta Oncol; 2002; 41(1):77-83. PubMed ID: 11990523
[TBL] [Abstract][Full Text] [Related]
33. The management and clinical course of testicular seminoma: 15 years' experience at a single institution.
Coleman JM; Coleman RE; Turner AR; Radstone CR; Champion AE
Clin Oncol (R Coll Radiol); 1998; 10(4):237-41. PubMed ID: 9764375
[TBL] [Abstract][Full Text] [Related]
34. Treatment of seminoma: does a positive HCG influence prognosis?
Bartsch G; Mikuz G; Frommhold H; Scheiber K
Prog Clin Biol Res; 1985; 203():483-4. PubMed ID: 2421340
[No Abstract] [Full Text] [Related]
35. [Biological markers and germinal tumors of the testis. Value and limitations of the assay of chorionic gonadotrophin hormone and alpha-fetoprotein].
Bassoulet J; Pabot du Chatelard P; Ricordel I; Auberget JL; Guillemot MC; Merrer J; Timbal Y
J Urol (Paris); 1988; 94(8):393-6. PubMed ID: 2467947
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of five tumor markers (AFP, CEA, hCG, hPL and SP1) in monitoring therapy and follow-up of patients with testicular germ cell tumors.
Szymendera JJ; Zborzil J; Sikorowa L; Leńko J; Kamińska JA; Gadek A
Oncology; 1983; 40(1):1-10. PubMed ID: 6185897
[TBL] [Abstract][Full Text] [Related]
37. Tumour markers in testicular germ cell tumours. Five-year experience from the DATECA Study 1976-1980.
Nørgaard-Pedersen B; Schultz HP; Arends J; Brincker H; Krag Jacobsen G; Lindeløv B; Rørth M; Svennekjaer IL
Acta Radiol Oncol; 1984; 23(4):287-94. PubMed ID: 6208749
[TBL] [Abstract][Full Text] [Related]
38. High frequency of incomplete human chorionic gonadotropin in patients with testicular seminoma.
Paus E; Fosså A; Fosså SD; Nustad K
J Urol; 1988 Mar; 139(3):542-4. PubMed ID: 2449547
[TBL] [Abstract][Full Text] [Related]
39. Abnormal liver enzymes and human chorionic gonadotropin elevation in abdominal testicular seminoma.
Hoard TD; Lewis EL
Urology; 1976 May; 7(5):512-4. PubMed ID: 5796
[TBL] [Abstract][Full Text] [Related]
40. Human chorionic gonadotropin and alphafetoprotein in the staging of nonseminomatous testicular cancer.
Bosl GJ; Lange PH; Fraley EE; Goldman A; Nochomovitz LE; Rosai J; Waldmann TA; Johnson K; Kennedy BJ
Cancer; 1981 Jan; 47(2):328-32. PubMed ID: 6161691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
